title: Mutations of the human interferon alpha-2b gene in brain tumor patients exposed to different environmental conditions.
abstract: This study was aimed at finding out mutations of an anticancerous, antiviral and immunomodulatory gene (human interferon alpha-2b) in low- and high-grade brain tumor patients and correlate from hematological profiles. A molecular analysis was performed in which DNAs were extracted from brain biopsy samples of brain tumor patients. The gene was amplified through the PCR technique, and genetic data from sequencing were analyzed by bioinformatics to determine how mutations will lead to changes in human interferon alpha 2b protein in patients. A total of 38% gene mutations were identified among brain tumor patients. The highest percentage of (36%) frameshift mutations was identified. Hematological analysis shows modulations in the 'lymphocytes' parameter in a majority (64%) of the brain tumor patients. Environmental factors have been reported as risks of brain cancer. Patients were found to be under environmental stress from contaminated drinking water and from local gamma radiations. Brain tumor patients were found to have various mutations in an immunomodulating human interferon alpha-2b gene. These patients had immunosuppression that was further affirmed from their hematological profiles. This analysis may be helpful to develop certain biomarkers that may be used to develop novel immunotherapeutical drugs, which enhance a better immune response.
authors.affiliation: College of Earth and Environmental Sciences, University of the Punjab, Lahore, Pakistan.
authors.forename: S
authors.initials: S
authors.lastname: Shahid
authors.affiliation: College of Earth and Environmental Sciences, University of the Punjab, Lahore, Pakistan.
authors.forename: M
authors.initials: M
authors.lastname: Nawaz Chaudhry
authors.affiliation: Department of Allied Health Sciences and Chemical Pathology, University of Health Sciences (UHS) Lahore, Lahore, Pakistan.
authors.forename: N
authors.initials: N
authors.lastname: Mahmood
authors.affiliation: Department of Neurosurgery, Shaikh Zayed Hospital, Federal Postgraduate Medical Institute, Lahore, Pakistan.
authors.forename: S
authors.initials: S
authors.lastname: Sheikh
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000235:genetics*; D004781:Environmental Exposure; D059647:Gene-Environment Interaction; D006801:Humans; D015994:Incidence; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000235:genetics*; D009154:Mutation; D011994:Recombinant Proteins / Q000235:genetics; D012307:Risk Factors
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
references.citation: Discov Med. 2014 Mar;17(93):145-54
references.pmid: 24641957
references.citation: Presse Med. 2010 Feb;39(2):e35-44
references.pmid: 19962851
references.citation: Mol Ther. 2011 Oct;19(10):1793-801
references.pmid: 21505426
references.citation: Cancer Res. 1995 Jul 15;55(14 ):3158-64
references.pmid: 7606736
references.citation: Int J Epidemiol. 2004 Dec;33(6):1209-16
references.pmid: 15567873
references.citation: Nat Rev Immunol. 2006 Nov;6(11):836-48
references.pmid: 17063185
references.citation: Neuro Oncol. 2011 Mar;13(3):345-52
references.pmid: 21339193
references.citation: Pharmacol Ther. 1993;58(1):93-132
references.pmid: 8415875
references.citation: Am J Epidemiol. 1999 Sep 15;150(6):552-60
references.pmid: 10489993
references.citation: Cell Death Differ. 2008 Jul;15(7):1153-62
references.pmid: 18404154
references.citation: J Neurosurg. 2003 Feb;98(2):378-84
references.pmid: 12593626
references.citation: Nat Genet. 2003 Mar;33(3):388-91
references.pmid: 12590259
references.citation: J Occup Environ Med. 2001 Apr;43(4):317-24
references.pmid: 11322092
references.citation: J Occup Environ Med. 2005 Jul;47(7):704-17
references.pmid: 16010197
references.citation: Occup Environ Med. 1994 May;51(5):295-8
references.pmid: 8199677
references.citation: PLoS Genet. 2006 Nov 10;2(11):e183
references.pmid: 17096597
references.citation: Ann Oncol. 2010 Oct;21 Suppl 7:vii167-72
references.pmid: 20943610
references.citation: Jundishapur J Nat Pharm Prod. 2012 Summer;7(3):111-6
references.pmid: 24624166
references.citation: Neurol Clin. 2007 Nov;25(4):867-90, vii
references.pmid: 17964019
references.citation: Springerplus. 2013 Jun 15;2(1):264
references.pmid: 23875128
references.citation: Am J Epidemiol. 2000 Nov 1;152(9):838-46
references.pmid: 11085395
references.citation: Radiat Res. 2011 Dec;176(6):796-806
references.pmid: 21936607
references.citation: Nature. 1993 Dec 9;366(6455):583-5
references.pmid: 7504785
references.citation: Cancer Causes Control. 1998 Mar;9(2):153-9
references.pmid: 9578292
references.citation: Front Oncol. 2014 Jul 21;4:126
references.pmid: 25101239
references.citation: Int J Occup Environ Med. 2011 Apr;2(2):82-111
references.pmid: 23022824
references.citation: Methods Mol Biol. 2009;472:323-42
references.pmid: 19107440
references.citation: Afr Health Sci. 2008 Mar;8(1):1-4
references.pmid: 19357723
references.citation: Science. 2008 Sep 26;321(5897):1807-12
references.pmid: 18772396
references.citation: Clin Cancer Res. 2010 Mar 1;16(5):1597-604
references.pmid: 20160062
references.citation: Cancer Res. 1997 Oct 1;57(19):4187-90
references.pmid: 9331072
references.citation: Cancers (Basel). 2013 Oct 23;5(4):1271-305
references.pmid: 24202446
references.citation: Hematology Am Soc Hematol Educ Program. 2008;:159-65
references.pmid: 19074075
references.citation: Nat Genet. 1997 Apr;15(4):356-62
references.pmid: 9090379
references.citation: Psychol Bull. 2004 Jul;130(4):601-30
references.pmid: 15250815
references.citation: Neuro Oncol. 2002 Oct;4(4):278-99
references.pmid: 12356358
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2010;94:v-vii, 1-412
references.pmid: 21141240
references.citation: Free Radic Biol Med. 2010 Dec 15;49(12):1846-55
references.pmid: 20826207
references.citation: Environ Health Perspect. 2004 Jul;112(10):A556-63
references.pmid: 15238298
references.citation: J Biosci. 2002 Dec;27(7):673-8
references.pmid: 12571372
references.citation: N Engl J Med. 2011 Feb 17;364(7):627-37
references.pmid: 21175304
references.citation: Curr Top Med Chem. 2005;5(12 ):1151-70
references.pmid: 16248789
references.citation: J Interferon Cytokine Res. 2002 Feb;22(2):173-88
references.pmid: 11911800
references.citation: Environ Health Perspect. 1995 Mar;103 Suppl 2:45-7
references.pmid: 7614946
references.citation: J Thromb Haemost. 2011 Feb;9(2):237-49
references.pmid: 21040448
references.citation: Brain Behav Immun. 2001 Mar;15(1):7-24
references.pmid: 11259077
references.citation: Cancer Res. 1996 Apr 1;56(7):1484-6
references.pmid: 8603389
references.citation: J Mol Biol. 1999 May 28;289(1):57-67
references.pmid: 10339405
references.citation: Recenti Prog Med. 2009 Feb;100(2):80-3
references.pmid: 19350799
references.citation: Cancer Sci. 2004 Nov;95(11):858-65
references.pmid: 15546502
references.citation: J Oncol. 2012;2012:416927
references.pmid: 22570651
references.citation: Pharmacol Rev. 2000 Dec;52(4):595-638
references.pmid: 11121511
references.citation: J Neuropathol Exp Neurol. 2007 Oct;66(10):944-54
references.pmid: 17917588
references.citation: Science. 1997 Mar 28;275(5308):1943-7
references.pmid: 9072974
references.citation: Protein Sci. 1996 Feb;5(2):331-40
references.pmid: 8745411
references.citation: Acta Neuropathol. 2008 Dec;116(6):597-602
references.pmid: 18985363
references.citation: FASEB J. 2005 Jun;19(8):998-9
references.pmid: 15802491
references.citation: Semin Cancer Biol. 2000 Apr;10 (2):83-92
references.pmid: 10936059
references.citation: J Interferon Cytokine Res. 1996 Feb;16(2):179-80
references.pmid: 8742371
references.citation: Am J Med. 2004 Apr 5;116 Suppl 7A:11S-26S
references.pmid: 15050883
references.citation: EuroIntervention. 2012 Jan;7(9):1081-6
references.pmid: 22207231
references.citation: Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9010-5
references.pmid: 19451644
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii12-7
references.pmid: 15146034
references.citation: J Leukoc Biol. 2002 Jun;71(6):907-20
references.pmid: 12050175
references.citation: J Pediatr Surg. 1970 Apr;5(2):111-6
references.pmid: 5419066
references.citation: Protein Expr Purif. 2010 Jun;71(2):139-46
references.pmid: 20159042
references.citation: Nat Clin Pract Neurol. 2006 Sep;2(9):494-503; quiz 1 p following 516
references.pmid: 16932614
references.citation: Gene Ther. 2004 Nov;11(21):1551-8
references.pmid: 15343358
references.citation: Hum Mol Genet. 2001 Apr;10(7):777-87
references.pmid: 11257112
references.citation: BMC Med Genomics. 2012 Sep 14;5:41
references.pmid: 22980038
references.citation: Brain Tumor Res Treat. 2013 Apr;1(1):2-8
references.pmid: 24904882
references.citation: PLoS One. 2013 Sep 16;8(9):e74435
references.pmid: 24066143
references.citation: Clin Cancer Res. 2010 Jan 15;16(2):461-73
references.pmid: 20068105
references.citation: J Natl Cancer Inst. 2008 Feb 20;100(4):270-6
references.pmid: 18270339
references.citation: Nat Rev Cancer. 2010 May;10(5):319-31
references.pmid: 20414201
references.citation: Oncoimmunology. 2012 May 1;1(3):298-305
references.pmid: 22737605
references.citation: Cancer. 2012 Sep 15;118(18):4530-7
references.pmid: 22492363
references.citation: Health Phys. 1998 Jul;75(1):63-6
references.pmid: 9645668
references.citation: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5259-63
references.pmid: 3134658
references.citation: J Radiol Prot. 2002 Dec;22(4):389-406
references.pmid: 12546226
references.citation: Cancer Res. 2004 Aug 1;64(15):5048-50
references.pmid: 15289301
references.citation: Environ Health. 2011 Apr 05;10 Suppl 1:S4
references.pmid: 21489214
references.citation: Annu Rev Biochem. 1998;67:227-64
references.pmid: 9759489
references.citation: Histol Histopathol. 2007 Mar;22(3):327-35
references.pmid: 17163407
references.citation: J Neurooncol. 2000 Apr;47(2):117-24
references.pmid: 10982152
references.citation: Nat Rev Immunol. 2012 Jan 06;12(2):125-35
references.pmid: 22222875
references.citation: J Natl Cancer Inst. 2002 Oct 16;94(20):1555-63
references.pmid: 12381708
references.citation: J Biol Chem. 2001 Jan 5;276(1):355-63
references.pmid: 11035028
references.citation: Am J Ind Med. 1998 Sep;34(3):252-60
references.pmid: 9698994
references.citation: Clin Cancer Res. 1999 Sep;5(9):2431-7
references.pmid: 10499615
references.citation: J Interferon Cytokine Res. 1999 Oct;19(10):1069-98
references.pmid: 10547147
references.citation: Radiat Res. 2005 Apr;163(4):424-32
references.pmid: 15799699
references.citation: J Mol Biol. 1999 Feb 12;286(1):151-62
references.pmid: 9931256
references.citation: Radiat Environ Biophys. 2010 May;49(2):177-85
references.pmid: 19855993
references.citation: Curr Neurol Neurosci Rep. 2007 May;7(3):208-14
references.pmid: 17488586
references.citation: Cancer Res. 1993 Jun 15;53(12 ):2736-9
references.pmid: 8504413
references.citation: J Neurooncol. 2010 Sep;99(3):307-14
references.pmid: 20821343